Year archive

Ocumension Therapeutics — 2023 filings

All 60 regulatory filings released by Ocumension Therapeutics (1477) in 2023, sourced directly from the official regulator.

60 Filings

2023 Period

2023 filings (60)

Filing	Released	Lang
Next Day Disclosure Return Transaction in Own Shares	2023-12-29	English
Next Day Disclosure Return Transaction in Own Shares	2023-12-28	English
Next Day Disclosure Return Transaction in Own Shares	2023-12-27	English
Next Day Disclosure Return Transaction in Own Shares	2023-12-22	English
Next Day Disclosure Return Transaction in Own Shares	2023-12-20	English
VOLUNTARY ANNOUNCEMENT APPROVAL RECEIVED FOR MARKETING OT-703 IN HONG KONG Regulatory Filings	2023-12-20	English
Next Day Disclosure Return Transaction in Own Shares	2023-12-19	English
Next Day Disclosure Return Transaction in Own Shares	2023-12-18	English
Next Day Disclosure Return Transaction in Own Shares	2023-12-15	English
Next Day Disclosure Return Transaction in Own Shares	2023-12-14	English
Next Day Disclosure Return Transaction in Own Shares	2023-12-13	English
INSIDE INFORMATION INCLUSION OF OT-401 IN CHINA NATIONAL REIMBURSEMENT DRUG LIST Regulatory Filings	2023-12-13	English
INSIDE INFORMATION INCLUSION OF OT-401 IN CHINA NATIONAL REIMBURSEMENT DRUG LIST Regulatory Filings	2023-12-13	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2023 Share Issue/Capital Change	2023-12-05	English
VOLUNTARY ANNOUNCEMENT PATIENT ENROLLMENT COMPLETED IN THE PHASE III CLINICAL TRIAL OF OT-502 IN CHINA Regulatory Filings	2023-11-29	English
VOLUNTARY ANNOUNCEMENT PROPOSED ON-MARKET SHARE REPURCHASE Transaction in Own Shares	2023-11-28	English
VOLUNTARY ANNOUNCEMENT PATIENT ENROLLMENT COMPLETED IN THE PHASE II CLINICAL TRIAL OF OT-202 IN CHINA Regulatory Filings	2023-11-22	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2023 Regulatory Filings	2023-11-03	English
SUPPLEMENTAL ANNOUNCEMENT Board/Management Information	2023-10-19	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2023 Regulatory Filings	2023-10-03	English
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG AND PROCESS AGENT Board/Management Information	2023-09-29	English
CHANGE OF JOINT COMPANY SECRETARIES AND AUTHORIZED REPRESENTATIVE Board/Management Information	2023-09-29	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS Report Publication Announcement	2023-09-26	English
NOTIFICATION LETTER AND REQUEST FORM TO REGISTERED SHAREHOLDERS Report Publication Announcement	2023-09-26	English
2023 Interim Report Interim / Quarterly Report	2023-09-26	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2023 Regulatory Filings	2023-09-04	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023 Interim / Quarterly Report	2023-08-24	English
NOTICE OF BOARD MEETING Regulatory Filings	2023-08-14	English
VOLUNTARY ANNOUNCEMENT PATIENT ENROLLMENT COMPLETED IN THE REAL-WORLD STUDY OF OT-502 IN HAINAN BOAO Regulatory Filings	2023-08-14	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2023 Regulatory Filings	2023-08-03	English
VOLUNTARY ANNOUNCEMENT CLINICAL TRIAL AUTHORIZATION FOR INITIATING A PHASE III CLINICAL TRIAL OF OT-101-S ACCEPTED IN CHINA Regulatory Filings	2023-07-20	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2023 Regulatory Filings	2023-07-04	English
AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2023-06-16	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 16, 2023 Declaration of Voting Results & Voting Rights Announcements	2023-06-16	English
VOLUNTARY ANNOUNCEMENT PATIENT ENROLLMENT COMPLETED IN THE GLOBAL MULTI-CENTER PHASE III CLINICAL TRIAL OF OT-101 Regulatory Filings	2023-06-01	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2023 Share Issue/Capital Change	2023-06-01	English
Next Day Disclosure Return Share Issue/Capital Change	2023-05-08	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2023 Share Issue/Capital Change	2023-05-05	English
VOLUNTARY ANNOUNCEMENT INCLUSION OF OT-1001 IN THE PRIORITY REVIEW AND APPROVAL PROCESS OF THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2023-04-26	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS Report Publication Announcement	2023-04-25	English
NOTIFICATION LETTER AND REQUEST FORM TO REGISTERED SHAREHOLDERS Report Publication Announcement	2023-04-25	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 16, 2023 Proxy Solicitation & Information Statement	2023-04-25	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2023-04-25	English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; PROPOSED RE-ELECTION OF RETIRING DIRECTORS; PROPOSED RE-APPOINTMENT OF AUDITOR; PROPOSED AMENDMENTS TO THE M AGM Information	2023-04-25	English
2022 Environmental, Social and Governance Report Environmental & Social Information	2023-04-25	English
2022 Annual Report Regulatory Filings	2023-04-25	English
VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION FOR OT-1001 ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2023-04-14	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2023 Regulatory Filings	2023-04-03	English
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE Remuneration Information	2023-03-30	English
PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE SIXTH MEMORANDUM AND ARTICLES OF ASSOCIATION Regulatory Filings	2023-03-30	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022 Annual Report	2023-03-30	English
DATE OF BOARD MEETING Regulatory Filings	2023-03-20	English
VOLUNTARY ANNOUNCEMENT PATIENT ENROLLMENT COMPLETED IN THE PHASE III CLINICAL TRIAL OF OT-702 IN CHINA Regulatory Filings	2023-03-13	English
VOLUNTARY ANNOUNCEMENT INITIATION OF THE PHASE II CLINICAL TRIAL OF OT-202 Regulatory Filings	2023-03-02	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 28 February 2023 Share Issue/Capital Change	2023-03-02	English
POSITIVE PROFIT ALERT Earnings Release	2023-02-13	English
VOLUNTARY ANNOUNCEMENT COMPLETION OF THE PHASE I CLINICAL TRIAL OF OT-202 Regulatory Filings	2023-02-02	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2023 Regulatory Filings	2023-02-02	English
VOLUNTARY ANNOUNCEMENT PATIENT ENROLLMENT COMPLETED IN THE PHASE III CLINICAL TRIAL OF OT-101 IN CHINA Regulatory Filings	2023-01-31	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2022 Share Issue/Capital Change	2023-01-06	English